CAUTION-Investigational Device. Limited by Federal or U.S. law to investigational use
KD Sievart, MD, PHD, FACS, FRCS
Professor Karl-Dietrich Sievert, MD, PhD, FACS, FRCS, was the Chair of Urology and Andrology at Salk Clinic and Parcelsus Medical University in Salzburg, Austria and Director of the Department of Urology at the University of Lubeck (UKSH). Previously he was the Vice Chair of Urology for more than 10 years at the University of Tabingen.
On his initiative, interdisciplinary incontinence centers were founded, which today are the standard of care. His knowledge of stem cell research and tissue engineering were a great benefit linking his clinical treatment and influencing his basic research (tissue regeneration, functional recovery after SCI, pharmacotherapy, neuromodulation).
Professor Sievert received his medical degree from the Ruprecht-Karls-University Medical School in Heidelberg and the University Clinic of Mannheim in Germany. He has been recognized for his surgical expertise by both the American and Royal College of Surgeons. His primary knowledge is the field of reconstructive and functional urology and he built his expertise as a highly skilled laparoscopic surgeon and certified DaVinci Console Surgeon.
Professor Sievert has participated in visiting professorships and held international training courses and is a board member of numerous urological and reconstructive surgery organizations. He is a recurring meeting contributor for his clinical and basic research work to the local and international community, including State-of-the-Art presentations in oncology, incontinence, tissue engineering and stem cell treatments.
Professor Sievert's clinical and basic research interests include oncology, neuro-urology, incontinence, reconstructive surgery, pharmacotherapy and the innovative treatment of SCI patients, which he was awarded the 2010 Klee Innovation Prize award and several patents. In recent years he became one of the few urologic experts in the stem cell and tissue-engineering field who has focused on the real-time processes of bringing research initiatives from the laboratory to clinic. .
